Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Bivalirudin on Aortic Valve Intervention Outcomes 2/3 (BRAVO 2/3)

NCT01651780 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT01651780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01651780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Bivalirudin on Aortic Valve Intervention Outcomes 2/3 (BRAVO 2/3)
Lead sponsor
The Medicines Company
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2012
Completion date
June 30, 2015
Enrollment
803 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve replacement, severe aortic stenosis, transcatheter aortic valve replacement